Published in Am J Pathol on December 01, 1997
Trefoil peptides. Gut (1999) 1.41
Gastric carcinogenesis by duodenal reflux through gut regenerative cell lineage. Dig Dis Sci (2003) 1.01
Ulcer associated cell lineage glands expressing trefoil peptide genes are induced by chronic ulceration in ileal pouch mucosa. Gut (2001) 0.87
Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res (1982) 5.14
Induction of a novel epidermal growth factor-secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature (1990) 3.20
Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res (1984) 2.52
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology (1995) 2.02
Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci U S A (1991) 2.01
hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J (1990) 1.95
The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol (1993) 1.56
Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology (1993) 1.55
Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology (1991) 1.54
1H NMR-based determination of the secondary structure of porcine pancreatic spasmolytic polypeptide: one of a new family of "trefoil" motif containing cell growth factors. Biochemistry (1992) 1.32
Rolling in the clover: trefoil factor family (TFF)-domain peptides, cell migration and cancer. FEBS Lett (1997) 1.29
The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol (1994) 1.23
Effect of gastroduodenal juice and dietary fat on the development of Barrett's esophagus and esophageal neoplasia: an experimental rat model. Ann Surg Oncol (1994) 1.17
The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol (1993) 1.17
Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype. J Pathol (1994) 1.02
The production and characterization of a new monoclonal antibody to the trefoil peptide human spasmolytic polypeptide. Histochem J (1994) 1.01
Esophagitis produced by reflux of duodenal contents in rats. Am J Dig Dis (1962) 1.01
Influence of esophagojejunostomy on the induction of adenocarcinoma of the distal esophagus in Sprague-Dawley rats by subcutaneous injection of 2,6-dimethylnitrosomorpholine. Cancer Res (1989) 0.95
Role of reflux oesophagitis and acid in the development of columnar epithelium in the rat oesophagus. Br J Surg (1993) 0.93
Expression of trefoil peptides in the gastric mucosa of transgenic mice overexpressing transforming growth factor-alpha. Growth Factors (1996) 0.92
The kinetic organization of the ulcer-associated cell lineage (UACL): delineation of a novel putative stem-cell region. Epithelial Cell Biol (1994) 0.83
Molecular aspects of restitution: functions of trefoil peptides. Yale J Biol Med (1997) 0.83
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
Hepatocytes from non-hepatic adult stem cells. Nature (2000) 3.27
The clinical assessment of proliferation and growth in human tumours: evaluation of methods and applications as prognostic variables. J Pathol (1990) 3.23
Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol (2001) 3.04
Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88
T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol (1997) 2.76
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
A comparison of immunohistochemical markers of cell proliferation with experimentally determined growth fraction. J Pathol (1991) 2.71
Clinical spectrum of bronchogenic cysts of the mediastinum and lung in the adult. Ann Thorac Surg (1991) 2.66
Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut (2008) 2.51
Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol (1990) 2.29
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet (1990) 2.22
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest (1999) 2.10
A novel gene (PLU-1) containing highly conserved putative DNA/chromatin binding motifs is specifically up-regulated in breast cancer. J Biol Chem (1999) 2.09
Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology (1993) 1.97
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol (1993) 1.89
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology (1998) 1.83
Bcl-2 expression in adult and embryonic non-haematopoietic tissues. J Pathol (1993) 1.78
Performance-based driving evaluation of the elderly driver: safety, reliability, and validity. J Gerontol (1994) 1.77
Short-term outcome analysis of a randomized study comparing laparoscopic vs open colectomy for colon cancer. Surg Endosc (1995) 1.74
The effect of starvation and refeeding on cell population kinetics in the rat small bowel mucosa. J Anat (1975) 1.73
Hepatocellular carcinoma and cirrhosis. Results of surgical treatment in a European series. Ann Surg (1996) 1.73
APC in the regulation of intestinal crypt fission. J Pathol (1998) 1.73
Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells. Proc Natl Acad Sci U S A (1998) 1.70
Crypt fission in the small intestine and colon. A mechanism for the emergence of G6PD locus-mutated crypts after treatment with mutagens. Am J Pathol (1995) 1.64
Observer variation and discriminatory value of biopsy features in inflammatory bowel disease. Gut (1994) 1.64
CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer. Gut (2010) 1.63
The kinetics of villus cell populations in the mouse small intestine. I. Normal villi: the steady state requirement. Cell Tissue Kinet (1982) 1.60
Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut (2002) 1.60
Coordinated localisation of mucins and trefoil peptides in the ulcer associated cell lineage and the gastrointestinal mucosa. Gut (2000) 1.59
Randomized clinical trial comparing inflammatory and angiogenic response after open versus laparoscopic curative resection for colonic cancer. Br J Surg (2010) 1.59
Molecular cloning and tissue expression of FAT, the human homologue of the Drosophila fat gene that is located on chromosome 4q34-q35 and encodes a putative adhesion molecule. Genomics (1995) 1.59
Stem cell in gastrointestinal structure and neoplastic development. Gut (2004) 1.57
The metaphase arrest technique. A critical review. Cell Tissue Kinet (1980) 1.57
Wnt5a cloning, expression, and up-regulation in human primary breast cancers. Clin Cancer Res (1995) 1.56
p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer. Br J Cancer (2004) 1.56
Experimental alveolar lipo-proteinosis following the inhalation of silica. J Pathol (1970) 1.56
The ulcer-associated cell lineage: the gastrointestinal repair kit? J Pathol (1993) 1.56
Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology (1993) 1.55
The stem cells of small intestinal crypts: where are they? Cell Prolif (2009) 1.55
Field cancerization, clonality, and epithelial stem cells: the spread of mutated clones in epithelial sheets. J Pathol (1999) 1.53
Triple-color FISH analysis of 12p amplification in testicular germ-cell tumors using 12p band-specific painting probes. J Mol Med (Berl) (1998) 1.50
Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer. J Clin Oncol (1998) 1.50
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patients. Eur J Cancer (1994) 1.49
Endocrine cells of the human gastrointestinal tract have no proliferative capacity. Histochem J (1995) 1.49
Bronchogenic cysts. J Pediatr Surg (1989) 1.48
hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci U S A (1993) 1.48
The epidermal growth factor receptor in human pancreatic cancer. J Pathol (1992) 1.47
Radionuclide esophageal transit study in detection of esophageal motor dysfunction: comparison with motility studies (manometry) J Nucl Med (1990) 1.47
Adaptation and validation of the Bristol scale stool form translated into the Spanish language among health professionals and patients. Rev Esp Enferm Dig (2009) 1.46
Circulating mesenchymal stem cells. Int J Biochem Cell Biol (2004) 1.43
Port site metastases and recurrence after laparoscopic colectomy. A randomized trial. Surg Endosc (1998) 1.42
Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine solid tumour types. J Pathol (1998) 1.41
Side populations of gastrointestinal cancers are not enriched in stem cells. J Pathol (2008) 1.41
Trefoil peptides. Gut (1999) 1.41
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res (1995) 1.40
Constipation with colonic inertia. A manifestation of systemic disease? Dig Dis Sci (1983) 1.40
[Endoscopic ultrasonography in the staging of esophageal cancer. Therapeutic implications]. Gastroenterol Hepatol (1998) 1.39
Cardiomyocyte differentiation of mouse and human embryonic stem cells. J Anat (2002) 1.38
Intestinal stem cells. J Cell Mol Med (2005) 1.37
Intravenous but not intragastric urogastrone-EGF is trophic to the intestine of parenterally fed rats. Gut (1987) 1.36
The effect of altered luminal nutrition on cellular proliferation and plasma concentrations of enteroglucagon and gastrin after small bowel resection in the rat. Br J Surg (1982) 1.36
A study of ras gene mutations in colonic adenomas from familial polyposis coli patients. Oncogene (1988) 1.35
Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow up of 107 patients. Gut (1994) 1.33
Prevalence of faecal incontinence and analysis of its impact on quality of life and mental health. Colorectal Dis (2010) 1.29
Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci U S A (1996) 1.29
Endotoxin and acute renal failure associated with obstructive jaundice. Br Med J (1970) 1.28
Does dietary fibre stimulate intestinal epithelial cell proliferation in germ free rats? Gut (1989) 1.28
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer (1995) 1.26
Pathological features of the colonic tumours induced in rats by the administration of 1,2-dimethylhydrazine. Virchows Arch B Cell Pathol (1978) 1.26
Stem cells and cancer: an intimate relationship. J Pathol (2006) 1.25
An alpha2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology (1999) 1.23
The ulceration-associated cell lineage (UACL) reiterates the Brunner's gland differentiation programme but acquires the proliferative organization of the gastric gland. J Pathol (1994) 1.23
Morphometry and cell proliferation in endoscopic biopsies: evaluation of a technique. Gastroenterology (1991) 1.22
Histogenesis of human colorectal adenomas and hyperplastic polyps: the role of cell proliferation and crypt fission. Gut (2002) 1.21
Intravenous epidermal growth factor/urogastrone increases small-intestinal cell proliferation in congenital microvillous atrophy. Lancet (1985) 1.21
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol (1998) 1.20
Up-regulation of macrophage wnt gene expression in adenoma-carcinoma progression of human colorectal cancer. Br J Cancer (1999) 1.19
Central effects of beta-adrenoceptor antagonists. I--Performance and subjective assessments of mood. Br J Clin Pharmacol (1988) 1.19
Interactions between stromal cell--derived keratinocyte growth factor and epithelial transforming growth factor in immune-mediated crypt cell hyperplasia. J Clin Invest (1998) 1.19
Paneth cell granule depletion in the human small intestine under infective and nutritional stress. Clin Exp Immunol (2004) 1.18